Study of fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease

Journal Title: International Journal of Clinical Biochemistry and Research - Year 2017, Vol 4, Issue 2

Abstract

Introduction: Liver biopsy and ultrasound are the gold standard methods to assess liver fibrosis in chronic liver disease (CLD). Recently Fibrosis Quotient test (Fibro Q test), AST: ALT Ratio (AAR) & AST: Platelet Ratio Indices (APRI) are the three non-invasive and simple indices proposed for assessing liver fibrosis in CLD. Objectives of the study: To know the efficacy of the indices- Fibro Q test, AAR, APRI as markers of fibrosis in CLD and to know which among these indices would be a high sensitive marker in estimating fibrosis. Materials and Method: The study includes 60 subjects, out of which 30 were clinically diagnosed as CLD and were confirmed by abdominal ultrasound (USG) and 30 were age and sex matched healthy controls. Fasting blood sample was collected; and AST, ALT, prothrombin time and platelet count were analysed. Fibro Q test, AAR & APRI were calculated. Receiver operating characteristic (ROC) curves were constructed to compare the accuracy of these three non-invasive tests in predicting significant fibrosis in patients with CLD. Results: Fibro Q, AAR, APRI were significantly increased in cases compared to controls. Fibro Q is a better marker than AAR & APRI, in the prediction of significant liver fibrosis. Conclusion: Fibro Q test, AAR & APRI indices are efficient markers to evaluate liver fibrosis in patients with CLD. Fibro Q, a novel non-invasive test, is a high sensitive marker than AAR & APRI.

Authors and Affiliations

Shilpa A. , Krishnaswamy D. , Indumati V. , Vijay V. , Shanthala D.

Keywords

Related Articles

Study of levels of malondialdehyde, super oxide dismutase and hsCrp in serum of non-obese patients with polycystic ovarian syndrome

Background: Polycystic ovarian syndrome (PCOS) is a heterogenous disorder with diverse clinical features. PCOS patients are known to develop long term complications like cardiovascular disease (CVD), type 2 diabetes mell...

Prevalence of Haemoglobinopathies in Punjabi population

Background: The prevalence of thalassemias and various hemoglobinopathies are a major public health problem in Punjabi population. These cases are mainly overlooked and thus only treated as a part of anaemia. Thus it is...

Assessment of glycated hemoglobin and uric acid level in polycystic ovarian syndrome in a Tertiary Care Institute of Marathwada region

Introduction: The Polycystic Ovary Syndrome (PCOS) is one of the most common reproductive endocrine disorders, affecting 5–10% of women in the reproductive age. Insulin resistance is the hallmark of this disorder. PCOS h...

Prevalence of overt and subclinical thyroid disease in patients tested for thyroid profile in CIMS Bilaspur (C.G.)

Background: Thyroid diseases are common worldwide. In India too, there is a significant burden of thyroid diseases. According to a projection from various studies on thyroid disease, it has been estimated that about 42 m...

Serum vascular endothelial growth factor-New scientific role in obesity

Background and Objectives: Obesity and related ailments are a major hassle across the world for many decades now. As per the published data from various sources overweight population between 1976 to 2002, [body mass inde...

Download PDF file
  • EP ID EP296979
  • DOI 10.18231/2394-6377.2017.0047
  • Views 72
  • Downloads 0

How To Cite

Shilpa A. , Krishnaswamy D. , Indumati V. , Vijay V. , Shanthala D. (2017). Study of fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease. International Journal of Clinical Biochemistry and Research, 4(2), 201-205. https://www.europub.co.uk/articles/-A-296979